Social media sites have begun deleting posts that mention abortion pills and specific versions such as mifepristone and misoprostol
TUESDAY, June 28, 2022 (HealthDay News) — Facebook and Instagram have started taking down posts that offer abortion pills to women who may not be able to get them after the Supreme Court’s reversal of Roe v. Wade. These posts told women how to get abortion pills through the mail even in states that had banned them.
Facebook and Instagram have begun deleting posts that mention abortion pills and specific versions of the pills such as mifepristone and misoprostol, the Associated Press reported. These posts also spiked Friday morning on Twitter, Facebook, Reddit, and TV broadcasts, according to the media intelligence firm Zignal Labs. By Sunday, Zignal had counted more than 250,000 mentions, the AP reported.
Posts for abortion pills on Facebook and Instagram were deleted moments after they appeared, the AP noted. A Facebook account was tagged with a “warning,” when Facebook said it violated its standards on “guns, animals, and other regulated goods.” However, when an AP reporter made the exact same post but changed the words “abortion pills” to “a gun,” the post remained untouched. The same thing happened to a post to mail “weed.”
Meta spokesperson Andy Stone told the AP that company policies ban the sale of certain items, including guns, alcohol, drugs, and pharmaceuticals. He did not explain the discrepancies in enforcing that policy. “We’ve discovered some instances of incorrect enforcement and are correcting these,” Stone acknowledged.
On Friday, Attorney General Merrick Garland said states should not ban mifepristone. “States may not ban mifepristone based on disagreement with the FDA’s expert judgment about its safety and efficacy,” he said in a statement.
Some Republicans have tried to stop their constituents from buying abortion pills through the mail, with West Virginia and Tennessee banning doctors from prescribing the pills via telemedicine, the AP reported.
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Study IDs Neurobiological Roots of Sensory Over-Responsivity